ZA201602375B - Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof - Google Patents
Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereofInfo
- Publication number
- ZA201602375B ZA201602375B ZA2016/02375A ZA201602375A ZA201602375B ZA 201602375 B ZA201602375 B ZA 201602375B ZA 2016/02375 A ZA2016/02375 A ZA 2016/02375A ZA 201602375 A ZA201602375 A ZA 201602375A ZA 201602375 B ZA201602375 B ZA 201602375B
- Authority
- ZA
- South Africa
- Prior art keywords
- polysaccharide
- preparation
- protein conjugates
- high yielding
- rapid high
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Toxicology (AREA)
- Sustainable Development (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2363DE2014 | 2014-08-20 | ||
IN3047DE2013 IN2013DE03047A (zh) | 2013-10-11 | 2014-10-10 | |
PCT/IB2014/065201 WO2015052684A2 (en) | 2013-10-11 | 2014-10-10 | Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201602375B true ZA201602375B (en) | 2017-07-26 |
Family
ID=52144766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2016/02375A ZA201602375B (en) | 2013-10-11 | 2016-04-08 | Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN105636608A (zh) |
MY (1) | MY194920A (zh) |
WO (1) | WO2015052684A2 (zh) |
ZA (1) | ZA201602375B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770890A (zh) * | 2016-03-08 | 2016-07-20 | 苏文全 | 一种特异性蛋白质组合物及其使用方法 |
CN106084037B (zh) * | 2016-06-08 | 2020-01-07 | 中国人民解放军第二军医大学 | 一种炭疽杆菌荚膜表面三糖缀合物及其制备方法和应用 |
MX2019002489A (es) | 2016-09-02 | 2019-10-21 | Sanofi Pasteur Inc | Vacuna contra neisseria meningitidis. |
US11027005B2 (en) | 2016-10-20 | 2021-06-08 | Km Biologics Co., Ltd. | Method for producing Hib conjugate vaccine using PRP with lowered molecular weight |
CN114965784B (zh) * | 2022-06-01 | 2023-10-27 | 艾美探索者生命科学研发有限公司 | 多糖活化度的测定方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100376361B1 (ko) * | 1993-09-22 | 2003-07-18 | 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신 | 면역원성구조체의제조를위하여신규한시아닐레이팅시약을사용하여용해성탄수화물을활성화하는방법 |
US8048432B2 (en) * | 2003-08-06 | 2011-11-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
GB201103836D0 (en) * | 2011-03-07 | 2011-04-20 | Glaxosmithkline Biolog Sa | Conjugation process |
-
2014
- 2014-10-10 CN CN201480056001.6A patent/CN105636608A/zh active Pending
- 2014-10-10 MY MYPI2016701265A patent/MY194920A/en unknown
- 2014-10-10 WO PCT/IB2014/065201 patent/WO2015052684A2/en active Application Filing
-
2016
- 2016-04-08 ZA ZA2016/02375A patent/ZA201602375B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN105636608A (zh) | 2016-06-01 |
WO2015052684A3 (en) | 2015-07-23 |
MY194920A (en) | 2022-12-23 |
WO2015052684A2 (en) | 2015-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL313147A (en) | Antibody-drug conjugates and methods for their preparation | |
IL267618B (en) | Methods of producing antibody-drug conjugates | |
IL244254A0 (en) | Engineered anti-dll3 conjugates and methods of use | |
IL244665B (en) | Conjugates of chlorotoxin and methods of using them | |
HK1218928A1 (zh) | 癌症疫苗及接種方法 | |
HK1211224A1 (zh) | 多價的糖結合疫苗 | |
SI2958944T1 (sl) | Konjugati protiDLL3-protitelo-PBD in njihove uporabe | |
GB201520943D0 (en) | Novel linker and preparation method thereof | |
IL286759A (en) | Therapeutic methods and preparations | |
ZA201602375B (en) | Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof | |
GB201301085D0 (en) | Glycoconjugate Vaccine | |
ZA201806043B (en) | Novel polysaccharide-protein conjugates and process to obtain thereof | |
HK1213800A1 (zh) | 類毒素、組合物及相關方法 | |
IL240031A0 (en) | A hard ballistic item and a process for its production | |
IL242584B (en) | An immunogenic preparation for use in treatment | |
IL245437A0 (en) | Antibodies against efna4 and antibody-drug pairs | |
HK1213917A1 (zh) | 類霉素、組合物及相關方法 | |
HUE050547T2 (hu) | Oligoszaccharid konjugátumok és alkalmazási eljárások | |
HK1219109A1 (zh) | 免疫原性組合物及其產生方法 | |
GB201411724D0 (en) | Improvements to packaging means and manufacture thereof | |
AU2013901875A0 (en) | Immunogenic vaccines and uses thereof | |
GB201306706D0 (en) | Novel process for preparation of antibody conjugates and novel antibody conjugates | |
GB201310472D0 (en) | Antibody-drug conjugates | |
GB201319255D0 (en) | Therapeutic compositions and methods | |
GB201314584D0 (en) | Improvements to packaging for toys and collectibles |